India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…
Importing generic medicines from India can deliver substantial savings, but the regulatory landscape is complex and varies significantly by destination country. This guide walks buyers through the key regulatory requirements,…
Buying Indian generic medicines across borders is one of the smartest ways to cut long-term healthcare costs, but the process is only smooth when you understand the customs, documentation and…
India's pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum.…